ADDvise Group AB (publ) (the “Company”) announces today that it will redeem in full its outstanding bond loan with ISIN SE0015222088 (the “Bonds” and “Early Redemption”) subject to the successful issuance of new bonds as announced by the Company through a press release on 11 May 2023. Provided that the conditions for Early Redemption are met (which will be announced separately), the Bonds will be redeemed on 9 June 2023 (the “Redemption Date”) at the redemption price of 103.625 per cent. of the nominal amount together with accrued but unpaid interest up to (and including) the Redemption Date (the “Redemption Price”). The Redemption Price will be paid to each person who is registered as owner of Bonds in the debt register maintained by Euroclear Sweden at the end of business on 1 June 2023. In connection with the Early Redemption, the Bonds will be de-listed from Nasdaq Stockholm. A notice of early redemption will be sent to holders directly registered in the debt register as owners of Bonds as per 11 May 2023. The notice of Early Redemption will also be available at the Company’s website www.addvisegroup.com.
For further information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se
Hanna Myhrman, General Counsel
+46 709-82 92 23
hanna.myhrman@addvisegroup.se
About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Premier and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.